http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1490121-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7b066c91d45fe3c5cb19fb02b7c9da16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
filingDate 1987-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1989-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b66ed8946f7e9ba0e6a48cdd2fca9545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a52d0fc5c91907003a8fd823d595210c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96e70802193a87dd543985384782d9b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05e14831ad9109b0f1be5d41d4d169bf
publicationDate 1989-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SU-1490121-A1
titleOfInvention Method of producing 5-hydroxy-5-methyl-4-oxo-3-arylpyrilidino /1,2-b/ pyrazols
abstract The invention relates to heterocyclic substances, in particular the preparation of 5-hydroxy-5-methyl-4-oxo-3-phenylpyrrolidino [1,2-B] pyrazole, or 5-hydroxy-5-methyl-4-oxo-3- [4- bromophenyl] pyrrolidino [1,2-B] pyrazole, or 5-hydroxy-5,6-dimethyl-4-oxo-3-phenylpyrrolidino [1,2-B] pyrazole — intermediates for the synthesis of vitasomnin group alkaloids. The goal is to increase the yield of target products of the extended range and simplify the process. It is carried out by reacting the corresponding 3- [2-methyl-2,3-epoxypropionyl] -4-aryl-2-pyrazoline with N-bromosuccinimide, followed by treatment with triethylamine. These conditions allow to reduce the staging of the process from 4 to 2 and to increase the yield of the target substances by 30-35%.
priorityDate 1987-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451165845
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67184
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457830920
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425914843
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546438
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21894497
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556587
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553602
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559213

Total number of triples: 31.